ABSTRACT

Background: Articaine is an amide local anaesthetic, which is gaining popularity for use in dental and oral surgical anaesthesia in the United Kingdom. Hitherto there has been insufficient evidence to recommend articaine above the more commonly used lidocaine for dental procedures. The aim of this study is to compare the efficacy of 4% articaine with 1:100,000 adrenaline (4AA) with that of 2% lidocaine with 1:100,000 adrenaline (2LA) administered as buccal infiltrations for anaesthesia in mandibular permanent first molar teeth. Any significant advantage noted may obviate the need for regional blockage of the inferior dental nerve in dental or minor oral surgical procedure under local anaesthesia. Objectives: To review the published literature comparing the efficacies of 4AA and 2LA for achieving pulpal anaesthesia in human mandibular permanent first molar teeth. Null Hypothesis: 4AA and 2LA are of equal efficacy when used to anaesthetize mandibular permanent first molar teeth by buccal infiltration. Method: An electronic search encompassing Ovid MEDLINE®, PubMed (National Center for Biotechnology Information, US National Library of Medicine), SCOPUS®, SCIRUS®, EMBASE® databases and the Cochrane Library was performed to identify trials relating to the efficacy of 4AA and 2LA local anaesthetic solutions on mandibular first molars in adult participants. Study characteristics and outcome data were extracted as a basis for meta-analysis. Results: Three randomised controlled trials were identified for this meta-analysis. The relative efficacy of 4AA over 2LA in anesthetizing permanent first mandibular molars was calculated at 1.57 (95% CI = 1.27 to 1.95). Conclusion: Despite the promising results shown in the metaanalysis it is difficult to say from the evidence presented that 4AA should be used clinically in preference over 2LA.

1. INTRODUCTION

Anaesthesia is a key component in the practice of dentistry. A range of local anaesthetic agents is widely available for use. Lidocaine is usually the anaesthetic of choice for most oral surgical procedures in the UK [1]; however, articaine has become increasingly available [2].

First introduced in 1976, 4% articaine solutions have shown high levels of anaesthetic potency and low systemic toxicity in clinical situations, due to its pharmacological profile and physicochemical characteristics [3]. Regional nerves blocks and local infiltration are the most commonly used anaesthetic administration techniques for mandibular teeth; however, buccal infiltration anaesthesia of the mandibular first molar would be beneficial to both clinicians and patients in terms of the ease and comfort [4].

The preference of a local infiltration over that of regional block has previously been described. For the clinician, the ease and speed of administration would be beneficial to the anxious patient. It has also been suggested that there might be fewer risks in patients taking anticoagulant therapies. If a local infiltration of Articaine could provide more effective analgesia than Lidocaine then it might be a preferable analgesic for use in most routine dental procedures.

The authors undertook this study to explore the possibility of using of Articaine (4AA) as a buccal infiltration alone to anesthetise mandibular first molar teeth, allowing dental, and some minor oral surgery procedures where surgical access is via the buccal cortex.

2. OBJECTIVES

To determine how effective buccal infiltration of 4AA is in producing mandibular permanent first molar pulpal anaesthesia when compared to 2LA.

3. MATERIALS AND METHODS

3.1. Literature Searching

The electronic databases of Ovid MEDLINE®, EMBASE®, PubMed®, Scopus ®, Scirus® and Cochrane Central Register of Controlled Trials were interrogated to identify relevant citations of published trials. In order to identify relevant unpublished or on-going trials further searches of the metaRegister of controlled trials register was also investigated. Table A1 gives the details of the databases searched along with the search strategies used. Attempts were made to contact the leading manufacturer of articaine within the UK (Septodont®) with regard to any information concerning on-going trials.

3.2. Selection of Studies

Randomised controlled trials (RCTs) fulfilling certain specified criteria were selected (Table 1). Cohort studies, case series and case reports are excluded from the review owing to the high potential for bias in these study designs. Case-control studies (except where nested as part of a cohort study) and economic evaluations are also excluded. Trials investigating the efficacy of buccal infiltrations of 4AA and 2LA administered to mandibular first molar teeth were included. A detailed list of the exclusion criteria is located in Table A2. The search process detailing the number of studies excluded at each point of the data collection is shown in Figure 1 and is detailed in Table A1.

3.3. Data Abstracts and Study Characteristics

The titles and abstracts obtained from the search were independently screened as suggested in the PRISMA protocol [5]. All obtained citations were checked to ensure that they fulfilled the inclusion criteria (Table 1). Those satisfying the criteria were then retrieved for analysis.

The data retrieved was extracted to Microsoft Excel® and included the authors, year of publication, study design, sample size, age range, intervention details with regards to the type of anaesthetic used and the measures of effectiveness were recorded (Table 2). The data detailing the time of onset and duration of onset of the anaesthetic were recorded; the data recorded for anaesthetic success was extracted. The data was analysed using StatsDirect®.

The assessment criteria according to COHORT [6] and individual study rating can be located in Table A3. All of the studies stated that appropriate approval and consent of participants was taken.

4. RESULTS

Studies published between 1946 and the present were included within the meta-analysis. The author and a review team screened 177 citations. Data from three randomised controlled trials were included within the statistical analysis (Tables 2 and 3).

The relative efficacy of articaine when compared to lidocaine was calculated for each of studies included (Table 3) and used to obtain the synthesis value (Table 4). This is best illustrated by the forest plot (Figure 2). Therefore, the relative efficacy of 4AA over 2LA in anesthetizing permanent first mandibular molars was calculated at 1.57 (95% CI = 1.27 to 1.95).

Cochrane’s Q and I² values were calculated from the raw data. Although though no significant heterogeneity was seen in the forest plot a random effects model was employed for the analysis due to the small number of relatively small studies included (as shown in Figure 2).

5. DISCUSSION

5.1. Key Findings

This meta-analysis suggests that the anaesthetic efficacy of 4AA when used as a mandibular buccal infiltration is greater than that of 2LA.

5.2. Biological and Clinical Interpretation

Though the mechanism for the increased efficacy of articaine is not fully understood, Skjevik et al. [10] have suggested that Articaine exhibits an exceptional effectiveness in bone tissue penetration along with an additional unique lipophilicity switch in its ability to form an intra-molecular hydrogen bond.

Many studies have investigated articaine buccal infiltration anaesthesia and its application with regards to maxillary and incisor teeth [11,12]. While some have reported no significant difference between the use of articaine or lidocaine [13] many maintain that 4AA is more effective than 2LA in achieving pulpal anaesthesia. Additionally, the onset of pulpal anaesthesia with articaine has been shown to be significantly faster than Lidocaine via buccal infiltration (P = 0.03), with a significantly longer duration of soft tissue anaesthesia (3.8 h vs. 2.5 h; P < 0.0001) [14,15].

5.3. Limitations

The included studies are based upon the use of 2% lidocaine with 1:100,000, adrenaline (epinephrine) whereas the most commonly used formulation for dental and oral surgical procedures in the UK employs adrenaline at the slightly higher concentration of 1:80,000. The concentration difference in vasoconstrictor may well account for a difference in clinical soft-tissue anaesthesia time mean-

ing that the use of 4AA may make little difference in this aspect.

The trials included in the meta-analysis all considered pulpal anaesthesia to have been achieved following the absence of response to the maximal stimulation (80 µA) with the electronic pulp tester on two or more episodes of testing. These results may not be directly transferable to oral surgical procedures such as the extraction of teeth which require anaesthesia of the structures surrounding the tooth.

As only a limited number of trails were available for inclusion within this meta-analysis it is premature to suggest that buccal infiltrations of 4AA in the mandibular region should be the anaesthetic agent and technique of choice.

5.4. Comparison to Previous Work

A meta-analysis conducted by Katyal, [16] investigating the efficacy and safety of articaine versus lidocaine in dental treatments supports the argument that articaine is more effective then lidocaine in providing anaesthetic success in the first molar region. Although higher pain scores for delivery were recorded, articaine has still been suggested as superior for use as an anaesthetic agent in dental treatment.

6. CONCLUSION

In this study 4AA has been shown to have greater efficacy in achieving pulpal anaesthesia in mandibular permanent first molar teeth than 2LA when administered via buccal infiltration on analysis of three studies. The increase in efficacy may be as high as 1.57. The small numbers of available studies in this analysis indicate that more work is required before the results can be directly translated into clinical practice.

ACKNOWLEDGEMENTS

I would like to thank Mr S. Parmar (Consultant in Oral and Maxillofacial Surgery) for his contribution to this work.

REFERENCES

APPENDIX